Build an AI Drug Discovery Pipeline: From Protein Sequence to Drug-Binding Hypothesis

“Can AI help us discover the next life-saving medicine?”

It sounds like science fiction, but AI is already transforming one of the most challenging fields in science—drug discovery.

Traditionally, developing a new drug can take 10–15 years and cost billions of dollars. One of the earliest and most difficult questions researchers face is:

Will this molecule bind to the protein responsible for a disease?

Finding that answer has historically required years of laboratory experiments and computational simulations.

Today, AI can dramatically accelerate this early research process.

In this hands-on project, we’ll build a simplified AI-assisted drug discovery pipeline that starts with nothing more than a protein sequence and ends with a data-driven drug-binding hypothesis.

Important: This workflow does not discover new drugs. Instead, it helps researchers prioritize promising candidates for further laboratory validation.

---

Research PDF

A formal research-style PDF version of this article is available here:

Suggested citation:
Pruseth, D. (2026). AI-Assisted Protein Analysis: From Sequence Representation to Drug-Binding Hypothesis Generation. Debabrata Pruseth AI Blog.

---

What You’ll Build

👉 The complete code is available on GitHub and can be run in environments like Google Colab.

By the end of this tutorial, you’ll know how to:

✅ Retrieve a protein sequence from a public database

✅ Predict its 3D structure using AlphaFold

✅ Evaluate the confidence of the prediction

✅ Dock a candidate molecule using AutoDock Vina

✅ Visualize the predicted interaction

✅ Generate an AI-assisted binding hypothesis

No prior biology knowledge is required.

---

Why Should AI Engineers Care About Biology?

You don’t need to become a biologist to appreciate this project.

Protein analysis is one of the best examples of how AI is moving beyond chatbots and image generation into solving real scientific problems.

The same machine learning principles you use for computer vision or natural language processing are now helping researchers understand diseases, discover medicines, and accelerate scientific breakthroughs.

Whether you’re an AI engineer, data scientist, or student, this project demonstrates how foundation models are reshaping scientific computing.

---

The Problem

Imagine you’re developing a medicine for a bacterial infection.

Scientists identify a protein that is essential for the bacteria to survive.

Your goal is simple:

Find a molecule that binds to this protein and blocks its function.

The challenge?

There may be millions of possible molecules.

Testing every one in a laboratory would be impossible.

Instead, researchers use AI and computational tools to narrow the search before conducting experiments.

---

Understanding Proteins—Without the Biology Degree

Think of a protein as a lock.

A drug molecule is the key.

If the key fits the lock correctly, it can change how the protein behaves.

Drug discovery is largely about finding the right key for the right lock.

The first challenge is understanding the shape of that lock.

That’s where AlphaFold comes in.

---

Step 1 – Retrieve the Protein Sequence

Every protein is made from a chain of amino acids.

This sequence acts like a recipe that determines how the protein folds into its final three-dimensional shape.

We’ll begin by downloading a protein sequence from a public database such as UniProt.

At this stage, we know what the protein is made of, but not what it looks like.

---

Step 2 – Predict the Protein Structure with AlphaFold

This is where AI becomes remarkable.

Instead of performing years of experimental structural biology, AlphaFold predicts the protein’s three-dimensional structure directly from its amino acid sequence.

You can think of AlphaFold as a specialised foundation model trained on proteins instead of language.

Just as a language model predicts the next word in a sentence, AlphaFold predicts how a protein folds into its most likely structure.

The output is a detailed 3D model that serves as the foundation for the rest of our analysis.

---

Step 3 – Can We Trust the Prediction?

Not every prediction is equally reliable.

AlphaFold provides a confidence score called pLDDT.

🔵 Blue → very high confidence

🟢 Green → good

🟡 Yellow → lower confidence

🔴 Red → unreliable

In our case, the structure is predominantly blue—indicating a highly reliable model.

---

Step 4 – Find a Candidate Drug Molecule

Now we need something that might interact with our protein.

Researchers often obtain small molecules from databases such as PubChem. We will use the same for our experiment.

Each molecule has a unique chemical structure that determines how it may interact with the protein.

Our objective is to determine whether these molecules might fit the protein’s binding pocket.

---

Step 5 – Molecular Docking

Now comes the exciting part.

Imagine trying thousands of different keys in a lock.

Some won’t fit.

Some will fit poorly.

A few may fit surprisingly well.

This is exactly what molecular docking software such as AutoDock Vina does.

It evaluates many possible orientations of a molecule inside the protein and estimates which interactions are most energetically favourable.

The result is a ranked list of possible binding poses.

---

Step 6 – Visualise the Interaction

Numbers alone don’t tell the whole story.

Visualising the docked complex helps us understand:

• Where the molecule binds
• Which amino acids are involved
• Whether important interactions such as hydrogen bonds are formed
• Whether the molecule blocks the active site

This step transforms computational predictions into something researchers can interpret.

---

Step 7 – Generate an AI-Assisted Hypothesis

At this stage, we’ve gathered several pieces of evidence:

• Protein sequence
• Predicted 3D structure
• Confidence scores
• Docking results
• Binding interactions

An LLM can now help summarise these findings into a clear, explainable hypothesis.

AI-Assisted Scientific Interpretation
Objective
The project aims to explore a mini-pipeline for AI-assisted structure-based drug discovery targeting E. coli dihydrofolate reductase (DHFR, folA). The approach involved predicting the 3D structure of E. coli DHFR using a ColabFold / AlphaFold2-style workflow, followed by molecular docking of a compound with AutoDock Vina to identify computationally plausible binding interactions.

Structural Model Quality
The predicted DHFR structure contains 159 residues with a high overall confidence indicated by a mean pLDDT score of 95.49. The majority of residues (146 out of 159) have pLDDT values above 90, representing very high confidence in local structural accuracy. Only 13 residues fall within the medium confidence range (70–90), and none below 70, suggesting a reliable model suitable for downstream docking analyses.

Docking Result Interpretation
The best docking score obtained from AutoDock Vina was −5.686 kcal/mol. While this score indicates a moderately favorable binding affinity, it should be regarded as an exploratory measure of ligand-target complementarity rather than a validated binding free energy. This interaction score supports prioritizing the compound for further computational and experimental investigation, recognizing the heuristics inherent to docking scoring functions.

Putative Interaction Zone
The docked ligand is predicted to interact with multiple residues within a 4.5 Å radius, including hydrophobic residues (ILE5, ILE14, ILE94), polar and charged residues (ASN18, ASP27, ARG98), and aromatic residues (PHE31, TYR100, HIS45). Glycine-rich loops (GLY95-97) and threonine side chains (THR46, THR123) also appear involved, which may contribute to binding through flexible loop regions or hydrogen bonding. This interaction cluster likely represents the putative ligand-binding site, consistent with the canonical substrate binding region of DHFR.

Scientific Limitations

The AlphaFold2-derived structure is a prediction, and despite high confidence, may not capture dynamic conformations or alternate binding site states.
Docking scores are simplified approximations and do not account for entropic effects, solvation dynamics, or induced fit conformational changes.
Experimental validation is necessary to confirm binding affinity and functional inhibition.
The ligand identity and chemical nature were not discussed, and off-target effects or bioavailability cannot be inferred.
The analysis does not consider potential allosteric sites or competitive binding with endogenous substrates/cofactors.

Notice the wording.

The AI is not making medical claims.

It is helping researchers interpret computational evidence.

---

The Complete AI Pipeline

Protein Sequence
        │
        ▼
AlphaFold Structure Prediction
        │
        ▼
Confidence Assessment
        │
        ▼
Candidate Molecule Selection
        │
        ▼
AutoDock Vina Docking
        │
        ▼
Binding Visualisation
        │
        ▼
LLM-Assisted Interpretation
        │
        ▼
Drug-Binding Hypothesis

---

Try It Yourself

Now that the pipeline works, experiment further:

• Analyse a different protein.
• Test multiple drug candidates.
• Compare docking scores.
• Visualise different binding poses.
• Investigate why one molecule performs better than another.

This is where real learning begins.

---

What This Project Cannot Tell Us

It’s important to understand the limitations.

This workflow does not prove that a drug works.

Computational predictions are only the beginning.

Any promising candidate must still undergo:

• Laboratory experiments
• Toxicity testing
• Animal studies
• Clinical trials

AI accelerates research—it does not replace scientific validation.

---

Real-World Applications

The same workflow is used across many areas of modern biotechnology:

• Antibiotic discovery
• Cancer research
• Rare disease research
• Vaccine development
• Protein engineering
• Precision medicine

As foundation models continue to improve, AI will increasingly become a standard tool for scientists working at the intersection of biology and computation.

---

Key Takeaways

In this project, you learned how AI can assist researchers throughout the early stages of drug discovery.

Starting from a simple protein sequence, we predicted its structure, assessed confidence, explored molecular docking, visualised potential interactions, and generated an explainable hypothesis.

More importantly, you saw that modern AI is no longer confined to text and images. It is becoming a powerful collaborator in solving some of humanity’s most complex scientific challenges.

---

Next Project

In the next article, we’ll explore another real-world AI application—using machine learning to predict fluid dynamics without solving complex physics equations. You’ll build a complete scientific AI project and see how foundation models are transforming engineering just as they are transforming biology.